A New Circulating Tumor Cell-Based Prognostic System To Refine Patient Stratification Status of Newly Diagnosed Multiple Myeloma Patients

被引：0
|
作者：
Kostopoulos, Ioannis [1 ]
Ntanasis-Stathopoulos, Ioannis [2 ]
Rousakis, Pantelis [1 ]
Malandrakis, Panagiotis [2 ]
Panteli, Chrysanthi [1 ]
Tsakirakis, Nikolaos [1 ]
Eleftherakis-Papaiakovou, Evangelos [2 ]
Angelis, Nikolaos [1 ]
Spiliopoulou, Vasiliki [2 ]
Syrigou, Rodaanthi-Eleni [2 ]
Bakouros, Panagiotis [1 ]
Dimitrakopoulou, Georgia [1 ]
Fotiou, Despina [2 ]
Migkou, Magdalini [2 ]
Kanellias, Nikolaos [2 ]
Gavriatopoulou, Maria [2 ]
Kastritis, Efstathios [2 ]
Dimopoulos, Meletios [2 ]
Tsitsilonis, Ourania [1 ]
Terpos, Evangelos [2 ]
机构：
[1] Natl & Kapodistrian Univ Athens, Sch Sci, Dept Biol, Flow Cytometry Unit, Athens, Greece
[2] Natl & Kapodistrian Univ Athens, Sch Med, Dept Clin Therapeut, Athens, Greece
来源：
CLINICAL LYMPHOMA MYELOMA & LEUKEMIA | 2024年 / 24卷
关键词：
D O I：
暂无
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
OA-20
引用
收藏
页码：S13 / S14
页数：2
相关论文
共 50 条
  • [31] High Levels of Circulating Tumor Cells Are Associated with Increased Bone Marrow Proliferation in Newly Diagnosed Multiple Myeloma Patients
    Fokkema, Cathelijne
    de Jong, Madelon M. E.
    Tahri, Sabrin
    Kellermayer, Zoltan
    den Hollander, Chelsea
    Vermeulen, Michael
    Papazian, Natalie
    van Duin, Mark
    Wevers, Michiel J. W.
    Sanders, Mathijs A.
    van der Velden, Vincent H. J.
    Sonneveld, Pieter
    Broyl, Annemiek
    Cupedo, Tom
    BLOOD, 2021, 138
  • [32] Plasma Cell Immunophenotyping Improve Prognostic Stratification of Multiple Myeloma Patients
    Meddour, Yanis
    Rahali, Momahed Cherif
    Belakehal, Salah Eddine
    Benfenatki, Nacera
    Ardjoune, Fatma Zohra
    Chaib, Samia
    Djidjik, Reda
    INTERNATIONAL JOURNAL OF CANCER MANAGEMENT, 2018, 11 (01)
  • [33] A Novel Biosignature for Potential Stratification and Elucidation of Newly Diagnosed Multiple Myeloma Patients at-Risk
    Kashif, Muhammad
    Zhou, Yijie
    Luong, Vincent
    Uttervall, Katarina
    Gahrton, Gosta
    Nahi, Hareth
    Alici, Evren
    Lund, Johan
    BLOOD, 2023, 142
  • [34] Significance of Modified Risk Stratification Msmart 3.0 and Autologous Stem Cell Transplantation for Patients with Newly Diagnosed Multiple Myeloma
    Garifullin, Andrey
    Voloshin, Sergei
    Shuvaev, Vasily
    Martynkevich, Irina
    Kleina, Elizaveta
    Chechetkin, Alexander
    Bessmeltcev, Stanislav
    Kuzyaeva, Anastasiya
    Hmidt, Alexander S.
    Kuvshinov, Alexey
    Pavlova, Irina
    BLOOD, 2019, 134
  • [35] The detection of circulating plasma cells may improve the Revised International Staging System (R-ISS) risk stratification of patients with newly diagnosed multiple myeloma
    Galieni, Piero
    Travaglini, Fosco
    Vagnoni, Davide
    Ruggieri, Miriana
    Caraffa, Patrizia
    Bigazzi, Catia
    Falcioni, Sadia
    Picardi, Paola
    Mazzotta, Serena
    Troiani, Emanuela
    Dalsass, Alessia
    Mestichelli, Francesca
    Angelini, Mario
    Camaioni, Elisa
    Maravalle, Denise
    Angelini, Stefano
    Pezzoni, Valerio
    BRITISH JOURNAL OF HAEMATOLOGY, 2021, 193 (03) : 542 - 550
  • [36] More than 2% circulating plasma cells as a prognostic biomarker in a large cohort of patients with newly-diagnosed multiple myeloma
    Mengru Tian
    Xinyue Liang
    Weiling Xu
    Xingcheng Yi
    Tingting Yue
    Yingjie Zhang
    Shanshan Yu
    Yurong Yan
    Zhongli Hu
    Nan Zhang
    Jingxuan Wang
    Rui Hu
    Xiaoxiao Sun
    Yuanyuan Nie
    Yun Dai
    Fengyan Jin
    Annals of Hematology, 2023, 102 : 2943 - 2945
  • [37] More than 2% circulating plasma cells as a prognostic biomarker in a large cohort of patients with newly-diagnosed multiple myeloma
    Tian, Mengru
    Liang, Xinyue
    Xu, Weiling
    Yi, Xingcheng
    Yue, Tingting
    Zhang, Yingjie
    Yu, Shanshan
    Yan, Yurong
    Hu, Zhongli
    Zhang, Nan
    Wang, Jingxuan
    Hu, Rui
    Sun, Xiaoxiao
    Nie, Yuanyuan
    Dai, Yun
    Jin, Fengyan
    ANNALS OF HEMATOLOGY, 2023, 102 (10) : 2943 - 2945
  • [38] Circulating plasma cells in newly diagnosed symptomatic multiple myeloma as a possible prognostic marker for patients with standard-risk cytogenetics
    Vagnoni, Davide
    Travaglini, Fosco
    Pezzoni, Valerio
    Ruggieri, Miriana
    Bigazzi, Catia
    Dalsass, Alessia
    Mestichelli, Francesca
    Troiani, Emanuela
    Falcioni, Sadia
    Mazzotta, Serena
    Natale, Annalisa
    Angelini, Mario
    Ferretti, Silvia
    Angelini, Stefano
    Galieni, Piero
    BRITISH JOURNAL OF HAEMATOLOGY, 2015, 170 (04) : 523 - 531
  • [39] A New Model for Risk Stratification in Patients with Newly Diagnosed Multiple Myeloma: Impact of Serum Free Light Chains in Prognosis
    Garcia de Veas Silva, Jose Luis
    Rojas Novoa, Johanna Carolina
    Bermudo Guitarte, Carmen
    Harding, Stephen
    Campos, Luisa
    Duro Millan, Rafael
    BLOOD, 2015, 126 (23)
  • [40] Efficacy and Prognostic Analysis of Percutaneous Vertebroplasty/Kyphoplasty in Patients with Newly Diagnosed Multiple Myeloma
    Zhang, Fujing
    Liu, Shuzhong
    Zhou, Xi
    Liu, Shuangjiao
    Liu, Yong
    Zhuang, Junling
    BLOOD, 2023, 142
12345